Musculoskeletal and Tissue Healing with BPC 157: Weight Loss and Vitality: Medical Weight Loss BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Big news in the peptide world. , The FDA has scheduled a formal hearing in July to review 7 peptides including BPC 157 and TB 500 for legal compounding. , This isnt approval. But its BREAKING: The FDA just made it official. Advisory committee meetings are now scheduled for July 23 24 to review reclassifying peptides back to legal compounding status. Here's what's happening: After the FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News